Skip to main content
. 2022 Jul 5;12:11380. doi: 10.1038/s41598-022-15778-3

Table 3.

Breast cancer screening rates for the period 2018–2020.

Characteristics 2018 (n = 1754a) 2019 (n = 1795a) 2020 (n = 1800a) 2019 versus 2018 2020 versus 2019
SR, %b SR, %b SR, %b SE SRR 95% CI SE SRR 95% CI
Overall 26.1 26.3 23.0 0.034 1.01 0.94–1.08 0.033 0.88 0.82–0.93
Age group, years
40–49 28.4 28.2 24.1 0.059 0.99 0.88–1.11 0.061 0.85 0.76–0.96
50–59 26.6 28.7 26.1 0.059 1.08 0.96–1.21 0.059 0.91 0.81–1.02
60–69 24.5 24.1 21.7 0.069 0.99 0.86–1.13 0.069 0.90 0.79–1.03
70–74 18.4 20.2 16.4 0.105 1.10 0.89–1.35 0.087 0.81 0.68–0.96
Residential area
Metropolitan 24.4 26.9 19.6 0.050 1.10 1.00–1.22 0.050 0.73 0.66–0.80
Urban 29.4 26.4 27.4 0.051 0.90 0.81–0.99 0.050 1.04 0.94–1.14
Rural 20.2 23.2 19.0 0.100 1.15 0.94–1.40 0.105 0.82 0.67–1.00
Monthly household income ($)
 ≤ 3999 22.4 24.7 22.3 0.057 1.10 0.99–1.23 0.056 0.90 0.81–1.01
4000–6999 27.4 23.6 20.9 0.056 0.86 0.77–0.96 0.058 0.89 0.79–0.99
 ≥ 7000 29.1 31.3 25.8 0.063 1.08 0.95–1.22 0.060 0.82 0.73–0.93
Education status
Middle school or lower 15.2 18.6 18.0 0.079 1.22 1.04–1.42 0.076 0.97 0.84–1.12
High school 27.7 28.0 23.0 0.044 1.01 0.93–1.10 0.044 0.82 0.75–0.90
College or higher 29.6 28.8 27.0 0.068 0.97 0.85–1.11 0.069 0.94 0.82–1.07
Chronic diseasec
No 25.3 27.4 22.0 0.043 1.08 0.99–1.18 0.044 0.80 0.74–0.88
Yes 27.2 24.5 24.2 0.054 0.90 0.81–1.00 0.052 0.99 0.89–1.09

SR screening rate, SRR screening rate ratio, SEstandard error, CI confidence interval.

aThe n value is the number of women eligible for breast cancer screening (aged over 40 years); bSRs were defined as the proportion of screened women within the last 1 year; Weighting values from the Population and Housing Census were applied to calculate the SRs; cChronic disease, women who are diagnosed with any of the following diseases: hypertension, diabetes, tuberculosis, hepatitis B, hepatitis C, liver cirrhosis, chronic gastritis, stomach/duodenal ulcers, polyps, benign breast diseases, uterine myoma, and hyperlipidemia.